Macular Degeneration Association

Therapeutic Areas: Oncology | Hematology

Hematologic Neoplasms Clinical Trials

A listing of Hematologic Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Hematologic Neoplasms

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

California

Los Angeles California 90027

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

San Francisco California 94143

A Phase 1 clinical study for patients with Hematologic Neoplasms

District of Columbia

Washington District of Columbia 20010

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Florida

Gainesville Florida 32610-0277

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Indiana

Community Clinical Research Center
Anderson Indiana 46011

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Maryland

Baltimore Maryland 21231

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

Baltimore Maryland 21287

A Phase 1 clinical study for patients with Hematologic Neoplasms

Massachusetts

Boston Massachusetts 02215

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Hematologic Neoplasms

Michigan

Detroit Michigan 48201

A Phase 1 clinical study for patients with Hematologic Neoplasms

Missouri

St. Louis Missouri 63110

A Phase 1 clinical study for patients with Hematologic Neoplasms

New Jersey

New Brunswick New Jersey 08903

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

New York

Bronx New York 10467

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

New York New York 10032

A clinical research study of BAY1251152 for the treatment of Hematologic Neoplasms

New York New York

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

New York New York 10021

A Phase 1 clinical study for patients with Hematologic Neoplasms

Oregon

Portland Oregon 97239

A Phase 1 clinical study for patients with Hematologic Neoplasms

South Carolina

Greenville South Carolina 29605

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tennessee

Nashville Tennessee 37232-6307

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Texas

Dallas Texas 75390

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Houston Texas 77030

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Houston Texas 77030

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

Houston Texas 77030

A Phase 1 clinical study for patients with Hematologic Neoplasms

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

San Antonio Texas 78229

A Phase 1 clinical study for patients with Hematologic Neoplasms

Washington

Seattle Washington 98109

A Phase 1 clinical study for patients with Hematologic Neoplasms

Australia

Bedford Park

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Darlinghurst

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Woolloongabba

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Czech Republic

Prague 150-06

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

France

Paris 75014

A clinical research study of Vemurafenib for the treatment of Solid Tumors, Hematologic Cancers or Metastatic Cancers

Villejuif Ile de France 94805

A clinical research study of Crizotinib for the treatment of Hematologic Cancers, Solid Tumors or Metastatic Cancer

Germany

Frankfurt 60590

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Hanover 30625

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Jena 07740

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Munster 48129

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Regensburg 93053

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Würzburg 97080

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Israel

Haifa

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Jeursalem

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Ramat Gan

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Tel Aviv

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Italy

Rome 00165

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Rome 00161

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Japan

Fukuoka

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies